Entera Bio Ltd. (FRA:5DT)

Germany flag Germany · Delayed Price · Currency is EUR
1.310
+0.002 (0.15%)
Jan 26, 2026, 2:25 PM EST
-39.35%
Market Cap52.88M -35.2%
Revenue (ttm)105.69K +25.3%
Net Income-9.19M
EPS-0.21
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume300
Average Volume108
Open1.310
Previous Close1.308
Day's Range1.310 - 1.310
52-Week Range1.220 - 2.660
Betan/a
RSI35.69
Earnings DateMar 9, 2026

About Entera Bio

Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial for the treatment of post-menopausal women with low bone mineral density and high-risk osteoporosis; and has completed Phase 1 clinical trial to treat ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 22
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5DT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements